Prognostic Role of C-reactive Protein in Gastric Cancer: A Meta-analysis |
Yu, Qing
(Department of Oncological Surgery, the First Affiliated Hospital, Zhejiang University)
Yu, Xiong-Fei (Department of Oncological Surgery, the First Affiliated Hospital, Zhejiang University) Zhang, Shou-De (Sir Run Run Shaw Hospital, Zhejiang University) Wang, Hao-Hao (Department of Oncological Surgery, the First Affiliated Hospital, Zhejiang University) Wang, Hai-Yong (Department of Oncological Surgery, the First Affiliated Hospital, Zhejiang University) Teng, Li-Song (Department of Oncological Surgery, the First Affiliated Hospital, Zhejiang University) |
1 | Ulich TR, Del CJ, Keys M, Granger GA, Ni RX (1987). Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes. J Immunol, 139, 3406-15. |
2 | Wang DS, Ren C, Qiu MZ, et al (2012). Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage iii gastric cancer. Tumour Biol, 33, 749-56. DOI ScienceOn |
3 | Wells GA, Shea B, O'Connell D, et al (2008). The newcastle-ottawa scale (nos) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm, Accessed 1 January 2008, |
4 | Woo Y, Hyung WJ, Obama K, et al (2012). Elevated high-sensitivity c-reactive protein, a marker of advanced stage gastric cancer and postgastrectomy disease recurrence. J Surg Oncol, 105, 405-9. DOI ScienceOn |
5 | Zheng ZX, Zheng RS, Chen WQ (2013). An analysis of incidence and mortality of stomach cancer in china, 2009. China Cancer, 327-32. |
6 | Aizawa M, Gotohda N, Takahashi S, Konishi M, Kinoshita T (2011). Predictive value of baseline neutrophil/lymphocyte ratio for t4 disease in wall-penetrating gastric cancer. World J Surg, 35, 2717-22. DOI |
7 | Balkwill F, Mantovani A (2001). Inflammation and cancer: back to virchow? Lancet, 357, 539-45. DOI ScienceOn |
8 | Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101. DOI ScienceOn |
9 | Bonner JA, Harari PM, Giralt J, et al (2006). Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med, 354, 567-78. DOI ScienceOn |
10 | Caruso R, Pallone F, Monteleone G (2007). Emerging role of il-23/il-17 axis in h pylori-associated pathology. World J Gastroenterol, 13, 5547-51. DOI |
11 | Catalano V, Labianca R, Beretta GD, et al (2009). Gastric cancer. Crit Rev Oncol Hematol, 71, 127-64. DOI ScienceOn |
12 | Chang CC, Sun CF, Pai HJ, et al (2010). Preoperative serum c-reactive protein and gastric cancer; Clinical-pathological correlation and prognostic significance. Chang Gung Med J, 33, 301-12. |
13 | Chen W, Zheng R, Zhang S, et al (2013). Report of incidence and mortality in china cancer registries, 2009. Chin J Cancer Res, 25, 10-21. |
14 | Correa P (1992). Human gastric carcinogenesis: a multistep and multifactorial process--first american cancer society award lecture on cancer epidemiology and prevention. Cancer Res, 52, 6735-40. |
15 | Coussens LM, Werb Z (2002). Inflammation and cancer. Nature, 420, 860-7. DOI ScienceOn |
16 | Egger M, Davey SG, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. DOI ScienceOn |
17 | Crumley AB, McMillan DC, McKernan M, McDonald AC, Stuart RC (2006). Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer. Br J Cancer, 94, 637-41. |
18 | Crumley AB, Stuart RC, McKernan M, McMillan DC (2010). Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer? World J Surg, 34, 2393-8. DOI |
19 | Cunningham D, Allum WH, Stenning SP, et al (2006). Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med, 355, 11-20. DOI ScienceOn |
20 | Forman D (2001). Gastric cancer and helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut, B, 347-53. |
21 | Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ (2003). Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer, 89, 1028-30. DOI ScienceOn |
22 | Gabay C, Kushner I (1999). Acute-phase proteins and other systemic responses to inflammation. N Engl J Med, 340, 448-54. DOI ScienceOn |
23 | Gencer D, Kastle-Larralde N, Pilz LR, et al (2009). Presentation, treatment, and analysis of prognostic factors of terminally ill patients with gastrointestinal tumors. Onkologie, 32, 380-6. |
24 | Hurlimann J, Thorbecke GJ, Hochwald GM (1966). The liver as the site of c-reactive protein formation. J Exp Med, 123, 365-78. DOI ScienceOn |
25 | Hashimoto K, Takashima A, Nagashima K, et al (2010). Progression-free survival in first-line chemotherapy is a prognostic factor in second-line chemotherapy in patients with advanced gastric cancer. J Cancer Res Clin Oncol, 136, 1059-64. DOI |
26 | Heikkila K, Ebrahim S, Lawlor DA (2007). A systematic review of the association between circulating concentrations of c reactive protein and cancer. J Epidemiol Community Health, 61, 824-33. DOI ScienceOn |
27 | Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60. DOI ScienceOn |
28 | Hwang JE, Kim HN, Kim DE, et al (2011). Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer. BMC Cancer, 11, 489. DOI |
29 | Iwasa S, Nakajima TE, Nakamura K, et al (2011). Systemic chemotherapy for peritoneal disseminated gastric cancer with inadequate oral intake: a retrospective study. Int J Clin Oncol, 16, 57-62. DOI |
30 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
31 | Jeong JH, Lim SM, Yun JY, et al (2012). Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer. Oncology, 83, 292-9. DOI ScienceOn |
32 | Kao SC, Pavlakis N, Harvie R, et al (2010). High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res, 16, 5805-13. DOI |
33 | Mantovani A, Allavena P, Sica A, Balkwill F (2008). Cancer-related inflammation. Nature, 454, 436-44. DOI ScienceOn |
34 | Karakiewicz PI, Hutterer GC, Trinh QD, et al (2007). C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a european study of 313 patients. Cancer, 110, 1241-7. DOI ScienceOn |
35 | Kwon HC, Kim SH, Oh SY, et al (2012). Clinicopathologic significance of expression of nuclear factor-kappab rela and its target gene products in gastric cancer patients. World J Gastroenterol, 18, 4744-50. DOI ScienceOn |
36 | Macdonald JS, Smalley SR, Benedetti J, et al (2001). Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med, 345, 725-30. DOI ScienceOn |
37 | Mohri Y, Tanaka K, Ohi M, et al (2010). Prognostic significance of host- and tumor-related factors in patients with gastric cancer. World J Surg, 34, 285-90. DOI |
38 | Nozoe T, Iguchi T, Adachi E, Matsukuma A, Ezaki T (2011). Preoperative elevation of serum c-reactive protein as an independent prognostic indicator for gastric cancer. Surg Today, 41, 510-3. DOI |
39 | Parsonnet J, Friedman GD, Vandersteen DP, et al (1991). Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med, 325, 1127-31. DOI ScienceOn |
40 | Pine JK, Fusai KG, Young R, et al (2009). Serum c-reactive protein concentration and the prognosis of ductal adenocarcinoma of the head of pancreas. Eur J Surg Oncol, 35, 605-10. DOI ScienceOn |
41 | Talmadge J E, Fidler I J (2010). Aacr centennial series: the biology of cancer metastasis: historical perspective. Cancer Res, 70, 5649-69. DOI |
42 | Proctor MJ, Morrison DS, Talwar D, et al (2011). An inflammation-based prognostic score (mgps) predicts cancer survival independent of tumour site: a glasgow inflammation outcome study. Br J Cancer, 104, 726-34. DOI ScienceOn |
43 | Sakuramoto S, Sasako M, Yamaguchi T, et al (2007). Adjuvant chemotherapy for gastric cancer with s-1, an oral fluoropyrimidine. N Engl J Med, 357, 1810-20. DOI ScienceOn |
44 | Shimura T, Kitagawa M, Yamada T, et al (2012). C-reactive protein is a potential prognostic factor for metastatic gastric cancer. Anticancer Res, 32, 491-6. |
45 | Tillett W S, Francis T (1930). Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med, 52, 561-71. DOI |
46 | Ulich TR, Del CJ, Guo K, Souza L (1989). The hematologic effects of chronic administration of the monokines tumor necrosis factor, interleukin-1, and granulocyte-colony stimulating factor on bone marrow and circulation. Am J Pathol, 134, 149-59. |
47 | Bonner JA, Harari PM, Giralt J, et al (2010). Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol, 11, 21-8. DOI ScienceOn |
48 | Parmar MK, Torri V, Stewart L (1998). Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med, 17, 2815-34. DOI |
49 | Fujitani K, Yamada M, Hirao M, Kurokawa Y, Tsujinaka T (2011). Optimal indications of surgical palliation for incurable advanced gastric cancer presenting with malignant gastrointestinal obstruction. Gastric Cancer, 14, 353-9. DOI ScienceOn |